Search

everythinglearnresearchcommunity

for

Search:↓

Genetic testing for cancer risk can lead to early and life-saving treatments in people without symptoms.

Breast cancer survivors may have a higher risk of falls, tamoxifen could prevent breast cancer and deaths, new guidelines urge caution with prostate cancer therapy, and early balding in men may indicate a higher prostate cancer risk.

Cancer therapy can cause various skin problems, including hair loss, skin darkening, painful hand-foot syndrome, and severe skin damage.

A 90-year-old woman's hand lesion was a rare, aggressive skin cancer treated successfully with surgery.

Pancreatic cancer pain management is inadequate due to the disease's severity and limited effectiveness of treatments.

Low dose oral minoxidil helps regrow hair in permanent chemotherapy-induced alopecia.

Epinephrine does not significantly affect the severity of hair loss after surgery.

Hair transplant is effective for treating hair loss caused by radiation and improves patients' quality of life.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Chemotherapy and bone marrow transplant can cause permanent hair loss.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

Balancing treatment effectiveness with side effects is crucial for relapsed follicular non-Hodgkin's lymphoma, especially in older patients.

Chemotherapy can cause skin side effects that affect patients' lives, but they can be managed to avoid interrupting cancer treatment.

Dietary supplements might help prevent post-COVID hair loss, but serum ferritin is not a reliable indicator.

Chemotherapy with docetaxel can cause painful nail and skin side effects that may lead to stopping treatment.

Chemotherapy in the first trimester of pregnancy is risky, but in the second and third trimesters, it's generally safe with careful drug selection and timing.

Using CDK inhibitors on rats showed a reduction in chemotherapy-caused hair loss, but later experiments could not repeat these results.

Scalp cooling can reduce chemotherapy-induced hair loss and should be available in all hospitals.

Bcl-2 overexpression protects against UVB damage but worsens hair loss from chemotherapy.

Using a gene therapy with the Sonic Hedgehog gene helps mice regrow hair faster after losing it from chemotherapy.

Scalp cooling is largely ineffective in preventing hair loss from breast cancer chemotherapy.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Oral retinoids are effective for treating severe skin disorders but have reversible side effects and risks for pregnant women.

Chemotherapy causes hair loss starting soon after treatment begins and recovers about 3 months after ending, while tamoxifen does not significantly affect hair growth.

Scalp cooling can prevent hair loss in 65% of chemotherapy patients, especially effective in breast cancer patients and certain chemotherapy types.

Better awareness of chemotherapy's side effects improves self-care.

Parathyroid hormones are important for hair growth, but their use in treating hair loss from chemotherapy is still uncertain.

Chemotherapy causes complex changes in hair follicle cells that can lead to hair loss.

M30 is a promising treatment for preventing hair loss during chemotherapy.